IBD center marketing: Crohn’s and colitis pages, urgent symptom wording, diet claims and teen transition

An inflammatory bowel disease (IBD) center is chosen by people who expect to need it for years. A college student with weeks of diarrhea and weight loss wants to know who can find out what is wrong. An adult with Crohn’s disease whose treatment stopped working wants a second opinion. A parent of a teenager with ulcerative colitis wants a team that will still be there when the child turns into an adult patient. The center may be a program inside a gastroenterology practice, a hospital IBD clinic, a pediatric GI team, or a group that pairs gastroenterologists with a colorectal surgeon, a dietitian, a psychologist and an infusion suite. This guide covers what the federal patient pages say, how to write about cure and remission, the urgent symptom wording each page needs, diet and supplement claims, treatment pages that stay current, surgery and ostomy pages, the move from pediatric to adult care, and money from drug makers and referral partners.

Nine related topics have their own guides and are not repeated here. Screening pages, colonoscopy cost wording, recall messages and GI referral basics are covered in our guide to gastroenterology practice marketing. Infused medicines, coverage wording, manufacturer copay coupons and drug names in Google Ads are covered in our guide to infusion center marketing. Parents, personal representatives and children’s privacy in general are covered in our guide to pediatric practice marketing. Selling supplements is covered in our guide to selling supplements in a medical practice, and nutrition services in our guide to dietitian marketing. Surveillance colonoscopy outreach is covered in our guide to colorectal cancer screening outreach, study recruitment in our guide to clinical trial recruitment ads, video visits in our guide to telehealth marketing, and support groups and education nights in our guide to patient education seminar marketing.

What NIDDK, MedlinePlus and HHS say

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) publishes the federal patient pages on Crohn’s disease and ulcerative colitis, MedlinePlus from the National Library of Medicine summarizes them and adds encyclopedia pages, and the Department of Health and Human Services (HHS) explains who controls a minor’s health information. The points that shape a center’s marketing:

• The NIDDK Crohn’s Disease Definition and Facts page (last reviewed July 2024) says Crohn’s disease is a chronic disease in which abnormal reactions of the immune system cause inflammation in the digestive tract, says symptoms range from mild to severe, and says that between flares a majority of people have periods of remission, when symptoms disappear, which can last for weeks or years. It says the goal of treatment is to keep people in remission long term. The Ulcerative Colitis Definition and Facts page (last reviewed September 2020) says the same about flares, remission and the goal of treatment.
• The NIDDK Crohn’s Disease Treatment page (last reviewed July 2024) says medicines do not cure Crohn’s disease but can reduce inflammation and bring on and maintain remission, and that surgery will not cure Crohn’s disease. The MedlinePlus Crohn’s Disease page (last updated October 18, 2023) says there is no cure, but treatments can decrease inflammation, relieve symptoms and prevent complications.
• The NIDDK Ulcerative Colitis Treatment page (last reviewed September 2020) says people with ulcerative colitis generally need lifelong treatment with medicines unless they have surgery to remove the colon and rectum. The MedlinePlus encyclopedia page Ulcerative colitis (review date January 13, 2026) says surgery to remove the colon will cure ulcerative colitis and removes the threat of colon cancer, and that cure is only possible through complete removal of the large intestine.
• The NIDDK Ulcerative Colitis Definition and Facts page says the disease can lead to serious complications that develop quickly and can be life-threatening, such as fulminant colitis, perforation, severe rectal bleeding and toxic megacolon, and that these require treatment at a hospital or emergency surgery. The NIDDK Crohn’s Treatment page says intestinal obstruction can be life-threatening.
• The MedlinePlus encyclopedia page Crohn disease (review date January 24, 2025) tells people to contact their provider for very bad abdominal pain, diarrhea that diet changes and medicines do not control, weight loss or a child not gaining weight, rectal bleeding, drainage or sores, a fever that lasts more than 2 or 3 days or a fever higher than 100.4 degrees Fahrenheit (38 degrees Celsius) without an illness, nausea and vomiting lasting more than a day, skin sores that do not heal, joint pain that prevents everyday activities, and side effects from medicines. The ulcerative colitis encyclopedia page gives a shorter list that includes ongoing abdominal pain, new or increased bleeding and a fever that does not go away.
• The NIDDK Crohn’s Disease Eating, Diet, and Nutrition page (last reviewed July 2024) says researchers have not found that specific foods cause or worsen Crohn’s disease symptoms, and the Ulcerative Colitis Eating, Diet, and Nutrition page (last reviewed September 2020) says the same for ulcerative colitis. Both NIDDK treatment pages tell readers to talk with their doctor before using dietary supplements or other complementary or alternative medicines or practices, for safety reasons.
• The NIDDK Definition and Facts pages say Crohn’s disease is more likely to develop in people between the ages of 20 and 29 and ulcerative colitis in people between 15 and 30, and both list problems with growth and development in children among the complications. The HHS guidance on personal representatives (content last reviewed January 5, 2024) says a parent is generally the personal representative of an unemancipated minor, names three circumstances in which the parent is not, and says the Privacy Rule defers to state or other law on a parent’s access to a minor’s information.

Two points shape the marketing. First, IBD is described by the federal pages as a long-term disease managed toward remission, so a page that promises a cure, a permanent remission or a diet that fixes it says more than the sources do. Second, the age ranges NIDDK names put teenagers and young adults at the center of the patient base, so the people who sign forms, read portal messages and give permission change while the patient is in the center’s care.

Writing about cure and remission

The words “cure” and “remission” carry the greatest weight on an IBD page, and the federal sources use them carefully. For Crohn’s disease, NIDDK says neither medicines nor surgery cure it, and MedlinePlus says there is no cure. For ulcerative colitis, the MedlinePlus encyclopedia says removal of the colon cures it, and NIDDK describes lifelong medicine unless the colon and rectum are removed. A center can quote those lines as written, with the source and its date. It should not write its own version.

Remission is a goal the agencies describe, not a promise a center can make. NIDDK says remission can last weeks or years and that the goal of treatment is long-term remission. A page can say the team works with each patient toward remission and explain what the team measures along the way, if it does. It should not say how long a remission will last, or that a patient will reach one.

Phrases that need rewriting:

• “Cure your Crohn’s.” NIDDK says medicines and surgery do not cure Crohn’s disease. Remove it, and quote the NIDDK goal of treatment instead.
• “Remission for life.” A promise no agency page supports. Say the team works toward remission with each patient and that the course of the disease differs from person to person.
• “Get off medication for good.” NIDDK says people with ulcerative colitis generally need lifelong treatment unless the colon and rectum are removed. Treatment changes are the clinician’s decision; describe how the team reviews them.
• “Surgery cures colitis” on its own. If a surgery page uses the word, quote the MedlinePlus encyclopedia sentence, name the operation it refers to, and describe the ostomy or reservoir that follows, as the next section explains.
• “Reverse the damage in your gut.” A health benefit claim with no source behind it. Describe what the team treats instead.

Urgent symptom wording on every page and in every tool

Put the MedlinePlus contact list and an emergency line on the IBD pages, above the booking button and the contact form. A short version a center can use, close to the source words: contact your provider for very bad abdominal pain, new or increased rectal bleeding, a fever higher than 100.4 degrees Fahrenheit (38 degrees Celsius) without another illness, vomiting that lasts more than a day, diarrhea that diet changes and medicines do not control, or weight loss. Then name the place to call: the center’s on-call line at [phone], with who answers it and when. NIDDK says complications of ulcerative colitis such as severe rectal bleeding, perforation and toxic megacolon can be life-threatening and require hospital treatment or emergency surgery, so add the general line: “If you think you are having a medical emergency, call 911.” Link the NIDDK and MedlinePlus pages so readers can check the wording.

The same wording belongs on voicemail, after-hours messages, patient portal autoreplies, text replies, chat widgets and AI front desk tools. A message that says “I am passing blood” or “I can’t stop throwing up” is not a scheduling request. The tool should give the urgent symptom wording, the on-call number and the 911 line at once and alert staff, not judge the symptom or offer the next open slot. Our guides to AI chatbots on practice websites and answering services and AI receptionists cover how those tools hand off urgent messages.

Phrases that need rewriting:

• “Having a flare? Book online.” Put the contact list, the on-call number and the 911 line first, and the booking form after them.
• “Message your IBD nurse about any symptoms.” Say who reads messages, during which hours, that the inbox is not watched around the clock, and give the on-call number and 911.
• “Skip the ER with same-day flare visits.” NIDDK names complications that need hospital treatment. Describe what a same-day visit is for and when the emergency department is the right place.
• “24/7 IBD support.” Only if a clinician from the team can be reached at every hour. Otherwise state [days and hours] and give the on-call and 911 wording for every other time.

Diet, supplement and gut health claims

Diet is where IBD marketing goes wrong fastest, because readers search for it and sellers answer. The NIDDK diet pages say researchers have not found that specific foods cause or worsen Crohn’s disease symptoms, and have not found that specific foods cause or worsen ulcerative colitis. They say a doctor may recommend changes to what a person eats and drinks depending on symptoms and medicines, may suggest a food diary, and may recommend dietary supplements when the body does not absorb enough nutrients. Both NIDDK treatment pages tell readers to talk with their doctor before using supplements or other complementary or alternative medicines or practices.

A center with a dietitian can describe what the dietitian does: a nutrition review, help with a food diary, meal planning during a flare, and work with the gastroenterologist on deficiencies. It should not sell a named diet as treatment. The FDA Questions and Answers on Dietary Supplements (content current as of August 27, 2026) says supplements do not need FDA approval before they are marketed, and that a product intended to diagnose, treat, cure or prevent a disease is a drug and not a supplement. A supplement sold at the front desk with a line about healing the gut lining in IBD is a disease claim.

Phrases that need rewriting:

• “The IBD diet that heals your gut.” NIDDK says researchers have not found that specific foods cause or worsen IBD symptoms. Describe the dietitian’s work and the food diary instead.
• “Our probiotic protocol puts colitis into remission.” A disease claim for a supplement and a remission promise. Remove it.
• “Natural alternative to biologics.” Steers readers away from treatment their clinician may recommend, and NIDDK tells readers to talk with their doctor before using complementary or alternative approaches. Remove it.
• “Microbiome reset program.” NIDDK says researchers are still studying the relationship between the microbiome and IBD. Do not sell a reset as treatment.
• “Food sensitivity testing finds your triggers.” The NIDDK pages describe a food diary, kept with the doctor, for finding foods that seem to make symptoms worse. If the center offers a test, say what it measures and what the clinician does with the result.

Under 15 U.S.C. 45, deceptive acts or practices in commerce are unlawful, and 15 U.S.C. 52 prohibits false advertisements likely to induce the purchase of drugs, devices, services or cosmetics. The FTC staff Health Products Compliance Guidance says claims about the health benefits or safety of health-related products require competent and reliable scientific evidence, and that an advertiser is responsible for the claims its ads convey, including implied ones. “Fewer flares with our program” is a health benefit claim even if no number appears.

Treatment pages that stay current

IBD treatment changes, and the federal pages show it. The NIDDK Crohn’s Treatment page, last reviewed July 2024, describes corticosteroids for short-term use, immunosuppressants, biologics and a newer small molecule medicine for adults who do not respond to other medicines. The NIDDK Ulcerative Colitis Treatment page was last reviewed in September 2020, so check for newer FDA or NIDDK information before a treatment page relies on it, and say on the page which source and date it follows.

Name no medicines in ads and no doses anywhere. On the treatment page, describe the categories the NIDDK pages use, link them, and put a “last reviewed” date on the page with [Clinician name, license] for the clinician who reviewed it. Set a review date, and review sooner when NIDDK or FDA posts a change. If the center has an infusion suite, the infusion guide covers coverage wording, copay coupons and drug names in Google Ads; link it rather than repeat it.

Phrases that need rewriting:

• “Now offering the newest IBD biologic” with a brand name. Name no product; say the team reviews treatment options with each patient.
• “Our patients stay in remission longer.” A results claim. Remove it unless the center has the data, the comparison and counsel’s review, and quote no number that is not sourced.
• “Steroid-free care.” NIDDK describes corticosteroids as a short-term treatment, and the clinician decides. Describe the team’s approach without implying a judgment on a medicine.
• “No more flares.” NIDDK describes flares and remission as the course of the disease. Remove it.

Surgery and ostomy pages

NIDDK says surgery will not cure Crohn’s disease and lists the reasons doctors recommend it, including fistulas, abscesses, intestinal obstruction, bleeding that is life-threatening, and symptoms that do not improve with medicines. For ulcerative colitis, NIDDK describes ileoanal reservoir surgery and an ileostomy, and says a patient considering surgery should talk with their doctor or surgeon about the type of surgery and its possible risks and benefits. For Crohn’s disease, NIDDK says a person who has a proctocolectomy and ileostomy will have the stoma for the rest of their life.

A surgery page for an IBD center can describe the operations the team performs, who performs them, and how the gastroenterologist and the surgeon decide together. It should say what living with a stoma involves, link the NIDDK page, and avoid framing surgery as either a failure or a fix. The MedlinePlus encyclopedia cure sentence for ulcerative colitis, if quoted, sits next to a plain description of what removal of the large intestine means. Our guide to robotic surgery advertising covers claims about surgical technique.

Phrases that need rewriting:

• “Surgery as a last resort.” Implies surgery is a failure. Describe when NIDDK says doctors recommend it.
• “Back to normal life after surgery.” A results claim. Describe recovery steps and who supports the patient.
• “Minimally invasive, minimal risk.” NIDDK says patients should talk with their surgeon about risks and benefits. Describe the approach and link the source.

Teens moving to adult care: forms, consent and portal access

A center that sees both teenagers and adults, or a pediatric GI program that hands patients to an adult IBD team, has a transition to plan and to describe. The marketing side of that is a page that tells families when planning starts, at [age], what the steps are and which adult team the patient moves to, plus forms, messages and portal settings that follow the patient as the rules change. NIDDK lists growth and development problems in children among the complications, so the pediatric side of the page can explain how the team watches growth and nutrition, without promising an outcome.

The HHS personal representatives guidance sets the frame. A parent is generally the personal representative of an unemancipated minor and controls the child’s health information. HHS names three exceptions: when state or other law does not require a parent’s consent for a particular service and the minor consents, when a court or other law lets someone other than the parent consent, and when a parent agrees to a confidential relationship between the minor and the provider. The Privacy Rule defers to state or other law on a parent’s access to a minor’s information. The definitions sit in 45 CFR 164.502(g). The age of majority, minor consent and parent access are set state by state.

For an IBD transition program, keep these points:

• Intake forms have a section the teen completes, and say plainly what the teen may discuss with the clinician in private and what the center shares with parents, in line with the state rules counsel confirms.
• Portal proxy access for parents is reviewed when the patient reaches adulthood under state law. The page says when that change happens and how the young adult can give a parent access again if they choose.
• Reminder texts and emails go to the number the patient chooses once they are an adult, and name no diagnosis, procedure or infusion in the message text.
• Infusion schedules, lab reminders and surveillance colonoscopy recalls move to the young adult’s contact details at the same point.
• School and college accommodation letters are shared with the permission of the person who controls the information at that time.
• A story, photo or video a parent authorized while the patient was a minor gets a fresh decision from the young adult before it is used again.

Our guides to patient portal messages, text message appointment reminders and patient photo consent cover each of those in more detail.

Prices and free offers

IBD care can involve repeat visits, scopes, imaging, labs and infusions, and readers ask what it costs. Our guides to advertising cash prices and good faith estimates for self-pay patients cover how to state a price and what uninsured and self-pay patients must receive. A “free IBD consultation” or “free nutrition review” follows 16 CFR 251.1, which says a free offer must not be recouped through a raised price or a reduced quantity or quality elsewhere, and the terms of the offer should be stated at the outset.

Referrals, drug maker support and community groups

IBD care draws partners: primary care offices, emergency departments, colorectal surgeons, infusion suppliers, specialty pharmacies, patient organizations, research sponsors and drug makers with patient support programs and nurse educators. Under 42 U.S.C. 1320a-7b(b), the federal anti-kickback statute, it is a crime to knowingly and willfully offer, pay, solicit or receive any remuneration to induce or reward referrals of items or services payable by a federal health care program. Where a center bills Medicare or Medicaid, the statute can reach each partnership on this list. Rules on referral fees are also set state by state. Our guide to patient and physician referrals covers the general rules.

For an IBD center, keep these points:

• Do not give gifts, meals, free services or payments to primary care offices, emergency departments or other referral sources in return for patients without counsel’s review.
• Grants, nurse educators, meals, speaker fees, staff or materials from a drug maker or specialty pharmacy go to counsel before any agreement is signed. Payments to physicians may be reported publicly; our guide to Open Payments covers that.
• A drug maker’s patient support or copay program is the maker’s program. Do not present it as the center’s own, and do not route patients to it as a condition of care.
• Support groups and education nights say who is paying, and a sponsor does not choose the speakers or the treatments discussed.
• Patients are not paid or given gifts for choosing the center or for referring others.
• Practices that see Medicaid patients follow the rules in our guide to marketing to Medicaid patients.

Privacy, pixels and ads

A visit to a Crohn’s disease page, a booking for an IBD second opinion or a sign-up for a support group says something about a person’s health. Keep bookings, intake answers, lab results, infusion schedules and page clicks out of tracking pixels and ad platform tools unless a written agreement covers them; our guide to tracking pixels on practice websites covers the setup. The Google Ads personalized advertising policy lists health among its sensitive interest categories and restricts targeting based on it. Ads can target by place and by search terms, and should not be built from a list of patients with IBD.

Under 45 CFR 164.501, a reminder about the practice’s own treatment for an individual, such as a follow-up visit or an infusion due, can fall outside the definition of marketing, while a message that promotes a third party’s product, such as a drug maker’s program, generally needs a signed authorization under 45 CFR 164.508. A message paid for by a drug maker needs counsel’s review before it goes out.

Patient stories

A young adult who describes finding a team after years of symptoms, or a patient who explains what life with an ostomy is like, can help a reader who is afraid of the same step. It is still one person’s experience. Under 16 CFR 255.2, an ad that shows one person’s result on a key attribute is likely to be read as what others will generally achieve, unless the advertiser has substantiation for that or clearly and conspicuously discloses what people can generally expect. “I have been in remission for years since I came here” is a results claim. Keep stories to the experience of care and the team, and pair them with the NIDDK wording that symptoms range from mild to severe and remission can last weeks or years.

Get a signed authorization under 45 CFR 164.508 where the practice is a covered entity, and consent for any photo or video. For a minor, the authorization comes from the person who controls the child’s information, and the young adult decides again at adulthood. Name no medicine, say if the patient received anything for taking part, and let the patient review the final version. Our guide to testimonials and before and after photos covers the full rules.

Illustration: two IBD center pages

Illustration: a page reads “Cure your Crohn’s and colitis for good. Our gut-healing diet and probiotic protocol put patients into lasting remission, and the newest named biologic is available here. Skip the ER with 24/7 flare support. Having a flare? Book online.” It promises a cure NIDDK says medicines and surgery do not provide for Crohn’s disease, sells a diet and a supplement as treatment, names a medicine, promises around-the-clock care it may not have, and puts a booking link where the urgent symptom wording belongs.

Illustration: a second page for the same practice reads “Call us at [phone] for very bad abdominal pain, new or increased rectal bleeding, a fever above 100.4 degrees Fahrenheit, or vomiting that lasts more than a day. If you think you are having a medical emergency, call 911. At [Practice name], [Clinician name, license] and the IBD team, including a dietitian and a colorectal surgeon, work with each patient toward remission, as the NIDDK describes the goal of treatment. Teens start planning their move to adult care at [age]; see how forms and portal access change. Clinic hours are [days and hours].” It puts the urgent wording first, describes the team and the goal in the agency’s words, and promises nothing it cannot show.

Checklist before an IBD campaign goes live

• NIDDK and MedlinePlus pages named and dated, with a “last reviewed” date and reviewer on the treatment page; the September 2020 ulcerative colitis pages checked against newer FDA or NIDDK information.
• Urgent symptom list, on-call number and the 911 line above any booking button, and in voicemail, portal replies, text replies, chat and AI front desk tools.
• “Cure” appears only as quoted agency wording, with the source; no promise of remission or of how long it lasts.
• No diet, probiotic, microbiome or food test sold as treatment; supplement copy follows the FDA Q&A and NIDDK’s talk-with-your-doctor line.
• No medicine names in ads and no doses; infusion pages follow the infusion guide.
• Surgery and ostomy pages describe the operations, the team and the NIDDK reasons for surgery, without fix or failure framing.
• Teen transition page with [age], steps and the adult team; teen sections on intake forms; portal proxy, reminder contacts and story authorizations reviewed at adulthood under state law.
• Free offers follow 16 CFR 251.1; cash prices and good faith estimates follow their guides.
• No gifts or payments to referral sources; drug maker and specialty pharmacy funding reviewed by counsel before signing; sponsors named.
• Bookings, results and infusion schedules stay out of pixels and ad audiences; targeting by place and search terms only.
• Stories have signed authorizations, name no medicine, make no results claim and carry a statement of what people can generally expect.

How we help

We build websites, local search, Google Ads and AI front desk tools for independent practices and health businesses, including gastroenterology practices that run IBD programs. For an IBD center, that means a site that quotes NIDDK and MedlinePlus as written, puts the urgent symptom wording above the booking button, explains the team, the dietitian’s role and the surgery options, and gives teens and parents a clear transition page, plus booking and second opinion forms that keep diagnoses and results off the web and away from tracking tools. Our front desk tools hand urgent messages to the urgent symptom wording, the on-call line and the 911 line, and do not triage symptoms. We do not decide who needs treatment; your clinicians do. Our tools are built with HIPAA in mind. We confirm in writing what a BAA covers before any patient information flows through a tool, and if it is not covered, we do not route patient information through it. We are not a healthcare provider and we do not give legal or medical advice. We do not sell lead lists and we do not pay for referrals. For the wider rules, see our healthcare marketing rules hub.

Sources

• NIDDK: Crohn’s Disease (last reviewed July 2024)
• NIDDK: Definition and Facts for Crohn’s Disease (last reviewed July 2024)
• NIDDK: Symptoms and Causes of Crohn’s Disease (last reviewed July 2024)
• NIDDK: Treatment for Crohn’s Disease (last reviewed July 2024)
• NIDDK: Eating, Diet, and Nutrition for Crohn’s Disease (last reviewed July 2024)
• NIDDK: Ulcerative Colitis (last reviewed September 2020)
• NIDDK: Definition and Facts for Ulcerative Colitis (last reviewed September 2020)
• NIDDK: Treatment for Ulcerative Colitis (last reviewed September 2020)
• NIDDK: Eating, Diet, and Nutrition for Ulcerative Colitis (last reviewed September 2020)
• MedlinePlus: Crohn’s Disease (last updated October 18, 2023)
• MedlinePlus: Ulcerative Colitis (last updated November 14, 2024)
• MedlinePlus Medical Encyclopedia: Crohn disease (review date January 24, 2025)
• MedlinePlus Medical Encyclopedia: Ulcerative colitis (review date January 13, 2026)
• FDA: Questions and Answers on Dietary Supplements (content current as of August 27, 2026)
• HHS: Personal Representatives (content last reviewed January 5, 2024)
• 15 U.S.C. 45: Unfair methods of competition unlawful
• 15 U.S.C. 52: Dissemination of false advertisements
• FTC: Health Products Compliance Guidance (December 2022)
• 16 CFR 251.1: Guide concerning use of the word free and similar representations
• 42 U.S.C. 1320a-7b: Criminal penalties for acts involving Federal health care programs
• 45 CFR 164.501: Definitions
• 45 CFR 164.502: Uses and disclosures of protected health information: General rules
• 45 CFR 164.508: Uses and disclosures for which an authorization is required
• 16 CFR 255.2: Consumer endorsements
• Google Ads: Personalized advertising policy

More in Physician specialty marketing